Trademark: 79361046
Word

Status
Registered
Status Code
700
Status Date
Tuesday, December 5, 2023
Serial Number
79361046
Registration Number
7232794
Registration Date
Tuesday, December 5, 2023
Mark Type
2000
Filing Date
Monday, November 7, 2022
Published for Opposition
Tuesday, September 19, 2023

Trademark Owner History
Sandoz AG -
Novartis AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all the aforesaid goods for human use
The mark consists of a stylized tear drop composed of a curved blue line on the right and ten magenta circles of various sizes forming a curved line on the left.
The color(s) magenta and blue is/are claimed as a feature of the mark.

Trademark Events
Mar 26, 2024
Final Decision Transaction Processed By Ib
Mar 7, 2024
Final Disposition Notice Sent To Ib
Mar 6, 2024
Final Disposition Processed
Mar 5, 2024
Final Disposition Notice Created, To Be Sent To Ib
Jan 19, 2024
Change Of Owner Received From Ib
Dec 5, 2023
Notice Of Registration Confirmation Emailed
Dec 5, 2023
Registered-Principal Register
Sep 19, 2023
Official Gazette Publication Confirmation E-Mailed
Sep 19, 2023
Published For Opposition
Sep 18, 2023
Notification Processed By Ib
Aug 30, 2023
Notification Of Possible Opposition Sent To Ib
Aug 30, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 30, 2023
Notification Of Notice Of Publication E-Mailed
Aug 10, 2023
Approved For Pub - Principal Register
Aug 8, 2023
Teas/Email Correspondence Entered
Aug 8, 2023
Correspondence Received In Law Office
Aug 8, 2023
Teas Response To Office Action Received
Aug 7, 2023
Refusal Processed By Ib
Jul 19, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Jul 19, 2023
Refusal Processed By Mpu
Jun 14, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Jun 13, 2023
Non-Final Action Written
Jun 12, 2023
Assigned To Examiner
Feb 7, 2023
Application Filing Receipt Mailed
Feb 3, 2023
New Application Office Supplied Data Entered
Feb 2, 2023
Limitation From Original Application Entered
Jan 26, 2023
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24